@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-S5PP1Z2N-S skos:prefLabel "Antagonistes des récepteurs bêta-1 adrénergiques"@fr, "Adrenergic beta-1 Receptor Antagonists"@en ; a mesh:Descriptor, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-QZBNR627-P mesh:allowableQualifier jvr:-R0ZCQ8X6-J, jvr:-G30ZJ446-J, jvr:-S0CS1X5R-5, jvr:-NHL3D2X0-S, jvr:-G4R176S9-J, jvr:-T9HQD7ST-J, jvr:-Q3979798-W, jvr:-W6SQV79N-S, jvr:-H7K65Q8S-Z, jvr:-R3QWLHRG-V, jvr:-L6C0XPHT-4, jvr:-TJHVZCRZ-0, jvr:-THHNVC7V-3, jvr:-FWD2BGQ0-9, jvr:-SBNWSM1T-R, jvr:-M63HSDM7-1, jvr:-NKM836P1-M, jvr:-CB30NGKB-3, jvr:-XV06LPML-W, jvr:-HQRFT0C6-B, jvr:-BT300B3G-Q, jvr:-NB0XHT3S-N, jvr:-WK5F724J-1, jvr:-NFTHND7Q-8, jvr:-D0F21513-5 ; a skos:Concept, mesh:Descriptor ; skos:hiddenLabel "Acebutolol Hydrochloride"@en, "Monitan"@en, "Novo-Acebutolol"@en, "M&B-17803A"@fr, "Rhotral"@en, "M&B-17803 A"@en, "Prent"@en, "M & B 17803A"@en, "M & B-17803A"@fr, "Chlorhydrate d'acébutolol"@fr, "Neptal"@en, "M & B17803A"@fr, "Apo-Acebutolol"@en, "M&B17803A"@fr, "Sectral"@fr, "Sectral"@en ; mesh:pharmacologicalAction jvr:-LS0SSBHQ-R, jvr:-PF128B09-N, jvr:-FG8LP9J8-Q, jvr:-S5PP1Z2N-S ; skos:inScheme jvr: ; skos:altLabel "Acetobutolol"@en, "Butanamide, N-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-, (+-)-"@en, "Butanamide, N-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-, (+-)-"@fr, "37517-30-9 (Acebutolol)"@fr, "37517-30-9 (Acebutolol)"@en, "Acétobutolol"@fr, "B025Y34C54"@fr, "B025Y34C54"@en, "67P356D8GH"@fr, "67P356D8GH"@en, "34381-68-5 (Acebutolol Hydrochloride)"@fr, "34381-68-5 (Acebutolol Hydrochloride)"@en ; skos:definition "A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action."@en ; dc:created "1974-11-19"^^xsd:date ; dc:established "1975-09-01"^^xsd:date ; skos:broader jvr:-XDH8VDDV-R ; dc:modified "2016-07-01"^^xsd:date ; skos:prefLabel "Acébutolol"@fr, "Acebutolol"@en ; owl:sameAs . jvr:-FG8LP9J8-Q skos:prefLabel "Antihypertensive Agents"@en, "Antihypertenseurs"@fr ; a mesh:Descriptor, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-XDH8VDDV-R skos:prefLabel "Phénoxypropanolamines"@fr, "Phenoxypropanolamines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-QZBNR627-P . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-LS0SSBHQ-R skos:prefLabel "Anti-Arrhythmia Agents"@en, "Antiarythmiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-PF128B09-N skos:prefLabel "Sympathomimétiques"@fr, "Sympathomimetics"@en ; a mesh:Descriptor, skos:Concept .